Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Wake

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Sports Sciences|November 19, 2010
Use of dual-task methodology for skill assessment and development: examples from rugby leagueTim Gabbett, Matthew Wake, Bruce Abernethy
Cell Reports|March 6, 2026
Structural basis for Rep-mediated adeno-associated virus packagingVictoria Xu, Aiysha McInnes, Matthew Wake, et al.
Journal for Immunotherapy of Cancer|June 8, 2026
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignanciesAung Naing, Chia-Chi Lin, Manish R Patel, et al.
Blood Advances|January 19, 2024
A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic miceMatthew Wake, Anaïs Palin, Audrey Belot, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Sports Sciences|November 19, 2010
Use of dual-task methodology for skill assessment and development: examples from rugby leagueTim Gabbett, Matthew Wake, Bruce Abernethy
Cell Reports|March 6, 2026
Structural basis for Rep-mediated adeno-associated virus packagingVictoria Xu, Aiysha McInnes, Matthew Wake, et al.
Journal for Immunotherapy of Cancer|June 8, 2026
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignanciesAung Naing, Chia-Chi Lin, Manish R Patel, et al.
Blood Advances|January 19, 2024
A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic miceMatthew Wake, Anaïs Palin, Audrey Belot, et al.
Pageof 1